help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pollesello, P.
Right arrow Articles by Ovaska, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pollesello, P.
Right arrow Articles by Ovaska, M.

Biophys J, April 1999, p. 1784-1795, Vol. 76, No. 4

Structure of the 1-36 Amino-Terminal Fragment of Human Phospholamban by Nuclear Magnetic Resonance and Modeling of the Phospholamban Pentamer

Piero Pollesello,* Arto Annila,# and Martti Ovaska*

 *Orion Corporation, Orion Pharma, Department of Pharmacology and Drug Discovery, Cardiovascular Research, FIN-02101 Espoo, and  #VTT, Chemical Technology, FIN-02044 VTT, Finland

The structure of a 36-amino-acid-long amino-terminal fragment of phospholamban (phospholamban[1-36]) in aqueous solution containing 30% trifluoroethanol was determined by nuclear magnetic resonance. The peptide, which comprises the cytoplasmic domain and six residues of the transmembrane domain of phospholamban, assumes a conformation characterized by two alpha -helices connected by a turn. The residues of the turn are Ile18, Glu19, Met20, and Pro21, which are adjacent to the two phosphorylation sites Ser16 and Thr17. The proline is in a trans conformation. The helix comprising amino acids 22-36 is well determined (the root mean square deviation for the backbone atoms, calculated for a family of 18 nuclear magnetic resonance structures is 0.57 Å). Recently, two molecular models of the transmembrane domain of phospholamban were proposed in which a symmetric homopentamer is composed of a left-handed coiled coil of alpha -helices. The two models differ by the relative orientation of the helices. The model proposed by Simmerman et al. (H.K. Simmerman, Y.M. Kobayashi, J.M. Autry, and L.R. Jones, 1996, J. Biol. Chem. 271:5941-5946), in which the coiled coil is stabilized by a leucine-isoleucine zipper, is similar to the transmembrane pentamer structure of the cartilage oligomeric membrane protein determined recently by x-ray (V. Malashkevich, R. Kammerer, V. Efimov, T. Schulthess, and J. Engel, 1996, Science 274:761-765). In the model proposed by Adams et al. (P.D. Adams, I.T. Arkin, D.M. Engelman, and A.T. Brunger, 1995, Nature Struct. Biol. 2:154-162), the helices in the coiled coil have a different relative orientation, i.e., are rotated clockwise by ~50°. It was possible to overlap and connect the structure of phospholamban[1-36] derived in the present study to the two transmembrane pentamer models proposed. In this way two models of the whole phospholamban in its pentameric form were generated. When our structure was connected to the leucine-isoleucine zipper model, the inner side of the cytoplasmic domain of the pentamer (where the helices face one another) was lined by polar residues (Gln23, Gln26, and Asn30), whereas the five Arg25 side chains were on the outer side. On the contrary, when our structure was connected to the other transmembrane model, in the inner side of the cytoplasmic domain of the pentamer, the five Arg25 residues formed a highly charged cluster.

Biophys J, April 1999, p. 1784-1795, Vol. 76, No. 4
© 1999 by the Biophysical Society   0006-3495/99/04/1784/12  $2.00



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. M. Kelly, Z. Hou, J. Bossuyt, D. M. Bers, and S. L. Robia
Phospholamban Oligomerization, Quaternary Structure, and Sarco(endo)plasmic Reticulum Calcium ATPase Binding Measured by Fluorescence Resonance Energy Transfer in Living Cells
J. Biol. Chem., May 2, 2008; 283(18): 12202 - 12211.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Zhao, Q. Yuan, J. Qian, J. R. Waggoner, A. Pathak, G. Chu, B. Mitton, X. Sun, J. Jin, J. C. Braz, et al.
The Presence of Lys27 Instead of Asn27 in Human Phospholamban Promotes Sarcoplasmic Reticulum Ca2+-ATPase Superinhibition and Cardiac Remodeling
Circulation, February 21, 2006; 113(7): 995 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. G. Paterlini and D. D. Thomas
The {alpha}-Helical Propensity of the Cytoplasmic Domain of Phospholamban: A Molecular Dynamics Simulation of the Effect of Phosphorylation and Mutation
Biophys. J., May 1, 2005; 88(5): 3243 - 3251.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. B. Karim, T. L. Kirby, Z. Zhang, Y. Nesmelov, and D. D. Thomas
Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone
PNAS, October 5, 2004; 101(40): 14437 - 14442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Chen, D. L. Stokes, W. J. Rice, and L. R. Jones
Spatial and Dynamic Interactions between Phospholamban and the Canine Cardiac Ca2+ Pump Revealed with Use of Heterobifunctional Cross-linking Agents
J. Biol. Chem., November 28, 2003; 278(48): 48348 - 48356.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. Zamoon, A. Mascioni, D. D. Thomas, and G. Veglia
NMR Solution Structure and Topological Orientation of Monomeric Phospholamban in Dodecylphosphocholine Micelles
Biophys. J., October 1, 2003; 85(4): 2589 - 2598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Hughes and D. A. Middleton
Solid-state NMR Reveals Structural Changes in Phospholamban Accompanying the Functional Regulation of Ca2+-ATPase
J. Biol. Chem., May 30, 2003; 278(23): 20835 - 20842.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Toyoshima, M. Asahi, Y. Sugita, R. Khanna, T. Tsuda, and D. H. MacLennan
Inaugural Article: Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase
PNAS, January 21, 2003; 100(2): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. G Schmidt, J. Zhai, A. N Carr, M. J Gerst, J. N Lorenz, P. Pollesello, A. Annila, B. D Hoit, and E. G Kranias
Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure
Cardiovasc Res, November 1, 2002; 56(2): 248 - 259.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
P. Pollesello and A. Annila
Structure of the 1-36 N-Terminal Fragment of Human Phospholamban Phosphorylated at Ser-16 and Thr-17
Biophys. J., July 1, 2002; 83(1): 484 - 490.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M. HOSHIJIMA, M. PASHMFOROUSH, R. KNOLL, and K.R. CHIEN
The MLP Family of Cytoskeletal Z Disc Proteins and Dilated Cardiomyopathy: A Stress Pathway Model for Heart Failure Progression
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 399 - 408.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Asahi, N. M. Green, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases
PNAS, August 28, 2001; 98(18): 10061 - 10066.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Asahi, E. McKenna, K. Kurzydlowski, M. Tada, and D. H. MacLennan
Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP
J. Biol. Chem., May 12, 2000; 275(20): 15034 - 15038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhai, A. G. Schmidt, B. D. Hoit, Y. Kimura, D. H. MacLennan, and E. G. Kranias
Cardiac-specific Overexpression of a Superinhibitory Pentameric Phospholamban Mutant Enhances Inhibition of Cardiac Function in Vivo
J. Biol. Chem., March 31, 2000; 275(14): 10538 - 10544.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Biophysical Society.